Harbin Pharmaceutical Group Co., Ltd.SSE: 600664

Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs

· Issued by Harbin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Harbin Pharmaceutical Group Co., Ltd. announced that its subsidiary has successfully passed the consistency evaluation for a generic drug.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Harbin Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Harbin Pharmaceutical

Later from Harbin Pharmaceutical

All Harbin Pharmaceutical news releases